The US contrast agents and radiopharmaceutical market was severely impacted by the COVID-19 pandemic in 2020, but has already shown significant recovery in 2021 and 2022; however, it continues to…
The COVID-19 pandemic negatively impacted the European contrast agents and radiopharmaceutical market in 2020. Following the recovery, growth in the European market will be supported by the…
December 21, 2021
September 23, 2021
November 20, 2020
November 11, 2020
November 27, 2014